Oncology focused, managed healthcare platform Karkinos Healthcare has raised an undisclosed amount of funding from Endiya Partners, one of India’s leading VC Funds in Technology, Healthcare and Life-sciences. The start-up is currently backed by Tata Group, Reliance Digital Health and Rakuten Medical, and many eminent industrialists such as Ratan Tata and Venu Srinivasan.
Karkinos Healthcare is pioneering the Distributed Cancer Care Network model in India, addressing clinical needs to bring quality care closer to cancer patients. According to World Health Organization (WHO) reports, one in every ten Indians is estimated to get cancer during their lifetime. Over 70 per cent of cancer cases in India are detected late, leading to poor health outcomes and survival rates.
Founded by a highly experienced team, Karkinos Healthcare started its operations in Kerala and is looking to expand to Tamil Nadu, Maharashtra, Karnataka and West Bengal. The company works with multiple healthcare institutions and professionals in the oncology ecosystem, successfully bringing cancer care closer to patients with a robust technology platform. It has also set up a Center for Advanced Cancer Diagnostics in Kochi to provide world-class diagnostic services for cancer, including molecular and immunohistochemistry tests. Recently, it announced a partnership with United Kingdom’s Guy’s and St. Thomas’ NHS Foundation Trust to collaborate on best-in-class practices in oncology care.
R. Venkataramanan, Founder and CEO, Karkinos Healthcare, said, “Endiya Partners, has been a premier early-stage investor in the Digital Health space, right from the inception with investments in various subsectors of health tech like AI in Radiology, AI in Pathology, Cell therapy for hitherto untreatable diseases, and tech-driven diabetes management/reversal programme and more.”
